The Chao Family Comprehensive Cancer Center (CFCCC) of the University of California, Irvine (UC Irvine) is the only NCI-designated comprehensive cancer center in Orange County, which is the sixth most populous U.S. county and home to more than 1 percent of the nation’s people. Now entering its 22nd year, the CFCCC will enact its new strategic plan to enhance its role as a vital resource for the people of Orange County and surrounding areas for generation and dissemination of new knowledge about the causes, prevention, and treatment of cancer, training of the next generation of cancer providers and caregivers, and alleviation of the overall burden of cancer on our citizens.
The CFCCC has a membership drawn from more than 32 academic departments across six schools at UC Irvine, including the schools of Medicine, Biological Sciences, Physical Sciences, Information & Computer Science, Engineering and Business. Our parent institution, UC Irvine, has been consistently ranked as the No. 1 U.S. university under 50 years old and the seventh such institution worldwide. CFCCC members are supported by extramural peer-reviewed cancer research funding, including funding from the NCI.
CFCCC research is organized into four research programs that provide an interactive and collaborative infrastructure for cancer discovery, clinical investigation including early phase and investigator-initiated trials, and population-based cancer research. These include a program focused on basic science (Chemical and Structural Biology), two programs spanning basic, translational, and clinical cancer research (Onco-Imaging and Biotechnology and Systems, Pathways & Targets), and our Population Science Program (Cancer Prevention, Outcomes & Survivorship).
The programs are further linked by the CFCCC disease-oriented teams that bring together basic, translational, patient-centered, and clinical investigators to facilitate the movement of CFCCC discoveries through the pipeline into the clinical arena. CFCCC research is supported by seven shared resources that provide our members access to specialized services, technology and instrumentation, and expert consultation and collaboration. These shared resources include the Transgenic Mouse Facility, Optical Biology Core, Genomic High-Throughput Facility, In Vivo Functional Onco-Imaging, Experimental Tissue Resource, Biostatistics Shared Resource, and the Biobehavioral shared resource. Clinical research is supported by the Stern Center for Cancer Clinical Trials & Research, the CFCCC clinical trials office